False-positive results of aspergillus galactomannan antigenemia in liver transplant recipients

Transplantation

Volumn 87, Issue 2, 2009, Pages 256-260

  Fortún, Jesus ^a   Martín Dávila, Pilar ^a   Alvarez, Maria E ^a   Norman, Francesca ^a   Sánchez Sousa, Aurora ^a   Gajate, Luis ^a   Bárcena, Rafael ^a   Nuño, S Javier ^a   Moreno, Santiago ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Antigenemia; Aspergillus; False positive; Galactomannan; Transplant

Indexed keywords

AMPICILLIN; CARBAPENEM; CASPOFUNGIN; CEFOTAXIMA; CEFOTAXIME; FUNGUS ANTIGEN; GALACTOMANNAN; GOBEMICINA; PIPERACILLIN PLUS TAZOBACTAM; TAZOCEL; UNCLASSIFIED DRUG; VANCOMYCIN; ANTIINFECTIVE AGENT; MANNAN;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; ASPERGILLOSIS; BLOOD SAMPLING; CONTROLLED STUDY; FALSE POSITIVE RESULT; FEMALE; GRAFT RECIPIENT; HUMAN; LIVER GRAFT; LIVER TRANSPLANTATION; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; ASPERGILLUS; BLOOD; CHEMISTRY; DRUG CONTAMINATION; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; LABORATORY DIAGNOSIS; PREDICTION AND FORECASTING; PROSPECTIVE STUDY; TIME;

AMPICILLIN; ANTI-BACTERIAL AGENTS; ANTIGENS, FUNGAL; ASPERGILLOSIS; ASPERGILLUS; DRUG CONTAMINATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE REACTIONS; HUMANS; LIVER TRANSPLANTATION; MANNANS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 59649096299     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31819288d5     Document Type: Article

References (30)

1. Stynen D, Goris A, Sarfati J, et al. A new sensitive sandwich enzyme-linked immunosorbent assay to detect galactofuran in patients with invasive aspergillosis. J Clin Microbiol 1995; 33: 497.
2. Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus. Clin Infect Dis 2002; 34: 7.
3. Pfeiffer CD, Fine JP, Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: A meta-analysis. Clin Infect Dis 2006; 42: 1417.
4. Mennink-Kersten MA, Donnelly JP, Verweij PE. Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. Lancet Infect Dis 2004; 4: 349.
5. Ansorg R, van den Boom R, Rath PM. Detection of Aspergillus galactomannan antigen in foods and antibiotics. Mycoses 1997; 40: 353.
6. MurashigeN, KamiM,KishiY, et al. False-positive results of Aspergillus enzyme-linked immunosorbent assays for a patient with gastrointestinal graft-versus-host disease taking a nutrient containing soybean protein. Clin Infect Dis 2005; 40: 333.
7. Asano-Mori Y, Kanda Y, Oshima K, et al. False-positive Aspergillus galactomannan antigenaemia after haematopoietic stem cell transplantation. J Antimicrob Chemother 2008; 61: 411.
8. Hamaki T, Kami M, Kanda Y, et al. False-positive results of Aspergillus enzyme-linked immunosorbent assay in a patient with chronic graftversus-host disease after allogeneic bone marrow transplantation. Bone Marrow Transplant 2001; 28: 633.
9. Dalle F, Emmanuel Charles P, BlancK, et al. Cryptococcus neoformans galactoxylomannan contains an epitope(s) that is cross-reactive with Aspergillus galactomannan. J Clin Microbiol 2005; 43: 2929.
10. Narreddy S, Chandrasekar PH. False-positive Aspergillus galactomannan (GM) assay in histoplasmosis. J Infect 2008; 56: 80.
11. Rimek D, Zimmermann T, Hartmann M, et al. Disseminated Penicillium marneffei infection in an HIV-positive female from Thailand in Germany. Mycoses 1999; 42(suppl 2): 25.
12. Giacchino M, Chiapello N, Bezzio S, et al. Aspergillus galactomannan enzyme-linked immunosorbent assay cross-reactivity caused by invasive Geotrichum capitatum. J Clin Microbiol 2006; 44: 3432.
13. Cummings JR, Jamison GR, Boudreaux JW, et al. Cross-reactivity of non-Aspergillus fungal species in the Aspergillus galactomannan enzyme immunoassay. Diagn Microbiol Infect Dis 2007; 59: 113.
14. Swanink CM, Meis JF, Rijs AJ, et al. Specificity of a sandwich enzyme-linked immunosorbent assay for detecting Aspergillus galactomannan. J Clin Microbiol 1997; 35: 257.
15. Mennink-Kersten MA, Klont RR, Warris A, et al. Bifidobacterium lipoteichoic acid and false ELISA reactivity in Aspergillus antigen detection. Lancet 2004; 363: 325.
16. Mennink-Kersten MASH, Ruegebrink D, Klont RR, et al. Bifidobacterial lipoglycan as a new cause for false-positive platelia Aspergillus enzyme-linked immunosorbent assay reactivity. J Clin Microbiol 2005; 43: 3925.
17. Surmont I, Stockman W. Gluconate-containing intravenous solutions: Another cause of false-positive galactomannan assay reactivity. J Clin Microbiol 2007; 45: 1373.
18. Meersseman W, Lagrou K, Maertens J, et al. Galactomannan in bronchoalveolar lavage fluid: A tool for diagnosing aspergillosis in ICU patients. Am J Respir Crit Care Med 2008; 177: 27.
19. Hage CA, Reynolds JM, Durkin M, et al. Plasmalyte as a cause of false-positive results for Aspergillus galactomannan in bronchoalveolar lavage fluid. J Clin Microbiol 2007; 45: 676.
20. Adam O, Aupérin A, Wilquin F, et al. Treatment with piperacillintazobactam and false-positive Aspergillus galactomannan antigen test results for patients with hematological malignancies. Clin Infect Dis 2004; 38: 917.
21. Aubry A, Porcher R, Bottero J, et al. Occurrence and kinetics of false-positive Aspergillus galactomannan test results following treatment with beta-lactam antibiotics in patients with hematological disorders. J Clin Microbiol 2006; 44: 389.
22. Walsh TJ, Shoham S, Petraitiene R, et al. Detection of galactomannan antigenemia in patients receiving piperacillin-tazobactam and correlations between in vitro, in vivo, and clinical properties of the drugantigen interaction. J Clin Microbiol 2004; 42: 4744.
23. Maertens J, Theunissen K, Verhoef G, et al. False-positive Aspergillus galactomannan antigen test results. Clin Infect Dis 2004; 39: 289.
24. Mattei D, Rapezzi D, Mordini N, et al. False-positive Aspergillus galactomannan enzyme-linked immunosorbent assay results in vivo during amoxicillin-clavulanic acid treatment. J Clin Microbiol 2004; 42: 5362.
25. Metan G, Durusu M, Uzun O. False positivity for Aspergillus antigenemia with amoxicillin-clavulonic acid. J Clin Microbiol 2005; 43: 2548.
26. Viscoli C, Machetti M, Cappellano P, et al. False-positive galactomannan platelia Aspergillus test results for patients receiving piperacillintazobactam. Clin Infect Dis 2004; 38: 913.
27. Wu DH. Platelia Aspergillus assay and potential cross-reaction. Clin Infect Dis 2004; 39: 1402.
28. Kappe R, Schulze-Berge A. New cause for false-positive results with the Pastorex Aspergillus antigen latex agglutination test. J Clin Microbiol 1993; 31: 2489.
29. Penack O, Schwartz S, Thiel E, et al. Lack of evidence that false-positive Aspergillus galactomannan antigen test results are due to treatment with piperacillin-tazobactam. Clin Infect Dis 2004; 39: 1401.
30. Marr KA, Laverdiere M, Gugel A, et al. Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay. Clin Infect Dis 2005; 40: 1762.